
Mount Sinai Spinoff Startup LinusBio Raises $16 Million in Series A funding
LinusBio, a 2021 spinoff company from Mount Sinai, announced a Series A venture capital funding to deliver a novel platform that bridges genomics, the environment, and biological response. The company’s platform is based on new methods and technology developed by scientists at the Institute for Exposomic Research at Mount Sinai.